ScienceDex / Researcher record
Akporiaye, Emmanuel T.
- Veana Therapeutics, Inc. (no department on record)
From the FY2021 NIH awards this investigator leads as contact PI. The department is the award's.
NIH Funding · FY2021
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2007 | $258,210 | 1 | #26,964 |
| 2008 | $258,210 | 2 | #26,754 |
| 2009 | $241,727 | 1 | #31,277 |
| 2010 | $248,463 | 1 | #31,825 |
| 2018 | $299,607 | 1 | #29,035 |
| 2019 | $50,521 | 1 | #42,262 |
| 2021 | $399,999 | 1 | #26,453 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20071 record
- FY20082 records
- FY20091 record
- FY20101 record
- FY20181 record
- FY20191 record
- FY2021 · selected1 record
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2007 through FY2021Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2021 award records by amount
NIH award records listing Akporiaye, Emmanuel T. as a PI. Multi-PI records show the full award amount for context.
- 1R43CA254606-01A1R43Contact PIPre-clinical Evaluation of a Novel Immune Modulator, Alpha-TEA-Lys in Combination with Trastuzumab Against HER2/neu Positive Breast Cancer$400Kaward amount
Award organization
Organizations that administered FY2021 awards listing Akporiaye, Emmanuel T. as a PI.
FY2021 award administered by Veana Therapeutics, Inc. ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2007First NIH AwardVeana Therapeutics, Inc.
- 2008$500K Cumulative Funding
- 2010$1M Cumulative Funding